Charles Explorer logo
🇨🇿

Corneal Cross-Linking with Riboflavin and UVA in Keratoconus

Publikace |
2016

Tento text není v aktuálním jazyce dostupný. Zobrazuje se verze "en".Abstrakt

Keratoconus is a degenerative ectopic disease of the eye, in which the cornea loses its stability. As a result, a bulging of the same occurs with increasing current thinning.

This results in an irregular corneal astigmatism as well as a high myopia, which leads to progressive vision impairment. Both eyes are affected, but in an asymmetrical form.

Due to the young age at first manifestation, the disease exerts a considerable influence on the further life quality and planning of the patients. The course of disease in this primary corneal ischaemia is very variable and influences the decision regarding the right treatment strategy.

An internationally recognized treatment regimen in the treatment of progressive keratoconus is called corneal collagen cross-linking (CXL). This method is used to delay or even stop a progress of this ectasia.

The need for corneal transplantation can thus be reduced.